Latest Administration News

Island Pharmaceuticals has completed its acquisition of the broad-spectrum antiviral Galidesivir and is progressing regulatory discussions with the FDA to fast-track approval using the Animal Rule, backed by compelling preclinical data.

Fluence Corporation reported a robust 72.9% revenue increase year-to-date Q3 2025, fueled by the Ivory Coast Addendum project, while maintaining its full-year guidance despite some margin pressures.

Fluence Corporation Limited reported a solid cash flow position for Q3 2025, with positive net cash from operations and strong liquidity supported by available financing facilities.

TZ Limited reports steady sales growth and new Microsoft contracts in Q1 FY2026, reaffirming its $17–21 million revenue guidance amid improving market conditions.

Petratherm Limited has significantly extended high-grade titanium mineralisation at its Rosewood East prospect and discovered a new Echo Prospect, advancing its Muckanippie Project towards a maiden resource.

Megado Minerals has secured all seven exploration permits for its flagship Iberian Copper Project in Northern Spain, advancing geological mapping and planning airborne geophysics and maiden drilling. The company also raised A$780,000 through an institutional placement and appointed a new independent director.

SomnoMed reports a strong start to FY26 with 13.5% revenue growth and confirms the Clayton Sleep Institute as the first US site for its pivotal Rest Assure clinical study, backed by FDA protocol agreement.

Li-S Energy has marked a milestone with the production of Australia’s first lithium metal foils and expanded its footprint in the global defense sector, supported by new manufacturing capabilities and strategic partnerships.

Little Green Pharma reported a robust September quarter with revenue exceeding $10 million, driven by growth across all product lines and strong European market performance. The company is poised to benefit from upcoming regulatory reforms and operational efficiencies.

Next Science reported a 3% rise in Q3 product sales and completed a $50 million asset sale to OSARTIS GmbH, setting the stage for a significant shareholder return.

Oneview Healthcare reported a €2.2 million net cash outflow in Q3 2025, impacted by delayed customer payments, while expanding its U.S. footprint with a new client and advancing deployments.

PentaNet Ltd reported a positive net operating cash flow of A$594,000 in the September 2025 quarter, bolstered by strong liquidity and ongoing investment in 5G infrastructure.